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Abstract
The prototype 1,4-dihydropyridine (1,4-DHP) nifedipine, indicated for the management of hyperten-
sion and angina pectoris, has drawbacks of rapid onset of vasodilating action and a short half-life.
Several newer analogues have been designed to offset these problems and these include mebudi-
pine and dibudipine. These analogues contain t-butyl substituents that have been selected to alter
the fast metabolism without altering pharmacological activity. In this study, the metabolism of
mebudipine and dibudipine by isolated rat hepatocytes has been investigated. These compounds
were extensively metabolized in 2h by oxidative pathways, analogous to those known for nifedi-
pine, and by O-glucuronidation after hydroxylation of the t-butyl substituents. The in-vitro half-lives
of mebudipine (22¯7.1min) and dibudipine (40¯ 9.8min) were significantly longer than that of
nifedipine (5.5¯ 1.1min), which was investigated in parallel in this study. These newer 1,4-DHPs
address the problem of the short half-life of nifedipine and have potential for further development
in view of their comparable potency to nifedipine.
Introduction
The 1,4-dihydropyridines (1,4-DHPs) inhibit the trans-membrane influx of calcium ions
into cardiac and vascular muscle cells and are indicated in the management of hyper-
tension and angina pectoris (Roden 2001). The prototype, nifedipine (see Figure 1), is
clinically effective but has a number of undesirable pharmacokinetic and pharmcody-
namic properties, which include a rapid onset of vasodilating action, a short half-life and
side effects such as reflex tachycardia, flushing, headache and dizziness (van Zwieten et al
1993; Borchard 1994). Nifedipine undergoes significant first-pass metabolism to highly
soluble inactive metabolites. Several newer 1,4-DHP analogues, which seek to overcome
these undesirable properties, have been developed and include amlodipine, felodipine,
lacidipine, nicardipine, nitrendipine and barnidipine (Roden 2001).
Recently, we reported the synthesis of two new 1,4-DHP calcium channel blockers,
mebudipine (see Figure 3) and dibudipine (see Figure 2) (Mahmoudian et al 1997). These
compounds contain t-butyl substituents selected to decrease the fast metabolism of the 1,4-
DHPs without altering their pharmacological activity. The incorporation of t-butyl sub-
stituents, as in terfenadine, has beenusedpreviously in drugdevelopment tomanipulate the
pharmacological half-life with some success. The half-life of the di (t-butyl) substituted
dibudipine (2.5 h) determined in-vivo in the rat was longer than those of other DHPs such
as nicardipine (0.1 h), benidipine (0.5 h), nisoldipine (0.4h), nitrendipine (1.3 h), felodipine
(1.5 h) and nilvadipine (1.3 h) (Teramura et al 1997) and comparable with that of the long-
acting amlodipine (Stopher et al 1988). Also in a previous study, the pharmacological
potencies of mebudipine and dibudipine were evaluated by studying their effects on
guinea-pig isolated ileumand the pIC50 values for the inhibition of the contractile response
to electrical stimulation were found to be similar to that of nifedipine (Mahmoudian et al
1997). The compounds also antagonize the contractile responses ofKþ depolarized guinea-
pig ileum to cumulative concentrations of calcium with the inhibitory effects in the order
mebudipine>nifedipine¼dibudipine. The vasorelaxant actions of mebudipine and dibu-
dipine have been reproduced in a human vascular preparation (Mahmoudian et al 1999).
